Key result
Higher spatial ventricular gradient magnitude is linked to ~68% lower PE adverse events per SD.
Why the study?
The spatial ventricular gradient reflects cardiac loading conditions, but whether it correlates with RV strain and predicts adverse events in acute PE was unknown.
Does the spatial ventricular gradient measured on ECG improve prediction of 30-day adverse outcomes compared to traditional ECG markers in patients with acute pulmonary embolism?
Cohort (n=317)
No
Does the spatial ventricular gradient measured on ECG improve prediction of 30-day adverse outcomes compared to traditional ECG markers in patients with acute pulmonary embolism?
Vectorcardiographic analysis of the spatial ventricular gradient (SVG) provides superior prognostic value for acute PE adverse events than classical ECG findings of right heart strain.
SVG magnitude may aid ECG prognostication in acute PE; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: The spatial ventricular gradient (SVG) is a vectorcardiographic measurement that reflects cardiac loading conditions via electromechanical coupling. OBJECTIVES: We hypothesized that the SVG is correlated with right ventricular (RV) strain and is prognostic of adverse events in patients with acute pulmonary embolism (PE). METHODS: Retrospective, single-center study of patients with acute PE. Electrocardiogram (ECG), imaging, and outcome data were obtained. SVG components were regressed on tricuspid annular plane systolic excursion (TAPSE), qualitative RV dysfunction, and RV/left ventricular (LV) ratio. Odds of adverse outcomes (30-day mortality, vasopressor requirement, or advanced therapy) after PE were regressed on demographics, RV/LV ratios, traditional ECG signs of RV dysfunction, and SVG components using a logit model. RESULTS: ECGs from 317 patients (48% male, age 63.1 ± 16.6 years) with acute PE were analyzed; 36 patients (11.4%) experienced an adverse event. Worse RV hypokinesis, larger RV/LV ratio, and smaller TAPSE were associated with smaller SVG X and Y components, larger SVG Z components, and smaller SVG vector magnitude (p < .001 for all). In multivariable logistic regression, odds of adverse events after PE decreased with increasing SVG magnitude and TAPSE (OR 0.32 and 0.54 per standard deviation increase; p = .03 and p = .004, respectively). Receiver operating characteristic (ROC) analysis showed that, when combined with imaging, replacing traditional ECG criteria with the SVG significantly improved the area under the ROC from 0.70 to 0.77 (p = .01). CONCLUSION: The SVG is correlated with RV dysfunction and adverse outcomes in acute PE and has a better prognostic value than traditional ECG markers.
No takes yet. Share an insight, caveat, or question.
Stabenau et al. (2023) conducted a cohort in Acute pulmonary embolism (PE) (n=317). Spatial ventricular gradient (SVG) magnitude vs. Traditional ECG markers of RV strain (S1Q3T3, RBBB, TWI) was evaluated on PE-related adverse events within 30 days (composite of mortality, vasopressor requirement, or advanced therapy) (OR 0.32 per standard deviation increase, 95% CI 0.12-0.90, p=0.031). Increasing spatial ventricular gradient magnitude was significantly associated with decreased odds of 30-day adverse events in acute pulmonary embolism (OR 0.32 per standard deviation increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: